These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 2398693)

  • 21. [Treatment of irreducible ascites of cirrhotic patients with peritoneo-jugular shunt].
    Capussotti L; Aricò S; Marucci M; Dellepiane M; De La Pierre M
    Minerva Med; 1982 Dec; 73(49-50):3477-84. PubMed ID: 7155396
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Surgical treatment of ascites with Le Veen shunt in patients with alcoholic liver disease].
    D'Albuquerque LA; de Oliveira e Silva A; Genzini T; de Miranda MP; dos Santos TE; Roldan-Molina F; Gama-Rodrigues J
    Arq Gastroenterol; 1990; 27(3):126-31. PubMed ID: 2099140
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Use of an autovenous valve for peritoneovenous shunting in patients with liver cirrhosis complicated by ascites].
    Malyshev IuI; Pyshkin SA; Pavlenko PP
    Klin Khir (1962); 1984 Sep; (9):36-8. PubMed ID: 6492621
    [No Abstract]   [Full Text] [Related]  

  • 25. [Experience with LeVeen peritoneal-venous shunt in the treatment of intractable cirrhotic ascites].
    Chen YR; Chen MC
    Zhonghua Nei Ke Za Zhi; 1983 Jul; 22(7):431-3. PubMed ID: 6641389
    [No Abstract]   [Full Text] [Related]  

  • 26. [12-year experience with continuous peritoneovenous shunt in the treatment of therapy-resistant ascites and hepatorenal failure: benefits and pitfalls].
    Kreuzer W
    Wien Klin Wochenschr; 1989 Jan; 101(2):87-91. PubMed ID: 2916345
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The Le Veen peritoneovenous shunt: presentation of 5 cases].
    Arcerito S; Torrisi V; Alongi G; Impellizzeri T; Neri A; Cicala S
    Chir Ital; 1981 Aug; 33(4):878-91. PubMed ID: 7326811
    [No Abstract]   [Full Text] [Related]  

  • 28. Peritoneovenous shunting of intractable ascites in patients with cirrhosis: improving results and predictive factors of failure.
    Hillaire S; Labianca M; Borgonovo G; Smadja C; Grange D; Franco D
    Surgery; 1993 Apr; 113(4):373-9. PubMed ID: 8456392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of surgical therapy in management of intractable ascites.
    Elcheroth J; Vons C; Franco D
    World J Surg; 1994; 18(2):240-5. PubMed ID: 8042329
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The LeVeen shunt in the elective treatment of intractable ascites in cirrhosis. A prospective study on 140 patients.
    Smadja C; Franco D
    Ann Surg; 1985 Apr; 201(4):488-93. PubMed ID: 3977450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Correction of hemodynamics after peritoneoatrial shunt in liver cirrhosis with resistant ascites].
    Vakhidov AV; Nazyrov FG; Akilov KhA; Kleĭnerman VE; Zorin AV
    Vestn Khir Im I I Grek; 1988 Feb; 140(2):26-9. PubMed ID: 3388703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognosis assessment of patients with refractory ascites treated with a peritoneovenous shunt.
    Nitta H; Okamura S; Mizumoto T; Matsushita H; Nishimura T; Shimokawa Y; Kimura M; Baba H
    Hepatogastroenterology; 2013 Oct; 60(127):1607-10. PubMed ID: 24634930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic value of preoperative tests in the surgical treatment of ascites with the implant of Le Veen shunts in cirrhotics.
    D'Albuquerque LA; de Oliveira e Silva A; Genzini T; de Miranda MP; Roldan-Molina F
    Arq Gastroenterol; 1991; 28(4):124-31. PubMed ID: 1843248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of intractable ascites in cirrhotic patients by portal shunt].
    Franco D
    Gastroenterol Clin Biol; 1983 May; 7(5):533-9. PubMed ID: 6873567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Peritoneovenous diversion using the LeVeen shunt in the treatment of refractory ascites after liver transplantation].
    Mabrut JY; de la Roche E; Adham M; Ducerf C; Baulieux J
    Ann Chir; 1998; 52(7):612-7. PubMed ID: 9805798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Sapheno-peritoneal shunt (Routte-operation) in the treatment of refractory ascites].
    Vincze K; Halmos F; Horváth G; Lelovics Z
    Magy Seb; 2003 Feb; 56(1):45-8. PubMed ID: 12764994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peritoneovenous shunts for malignant ascites.
    Sonnenfeld T; Tydén G
    Acta Chir Scand; 1986 Feb; 152():117-21. PubMed ID: 3953206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Salvaging procedures for dysfunctional peritoneovenous shunt.
    Hu RH; Lee PH
    Hepatogastroenterology; 2001; 48(39):794-7. PubMed ID: 11462926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Characteristics of portal-lymphatic hypertension and surgical treatment of patients with cirrhosis of the liver and persistent ascites].
    Nazyrov FG; Khoroshaev VA; Deviatov AV; Vakhidov AV
    Vestn Khir Im I I Grek; 1989 Feb; 142(2):104-6. PubMed ID: 2728224
    [No Abstract]   [Full Text] [Related]  

  • 40. [Surgical treatment of ascites in cirrhosis of the liver].
    Shalimov AA; Kalita NIa; Kotenko OG; Bulakov KI
    Khirurgiia (Mosk); 1990 Jan; (1):38-41. PubMed ID: 2329741
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.